UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

At the same time, with a growing number of clinics dispensing the psychedelic drug ketamine as a treatment for depression, a vital question arises. Is ketamine a breakthrough, or are so-called ...

Traditional antidepressants take months to kick in, which increases the risk for some patients to act on suicidal thoughts during the initial period of treatment ... research explains how low-dose ...

Ketamine is related to the recreational drug phencyclidine (PCP). Studies have found that low doses of ketamine can quickly ...

This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression. The past ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Waterloo region is home to a new clinic that offers a psychedelic treatment method ... benefits. Ketamine-assisted psychotherapy involves taking a controlled dose of ketamine under the ...

A mid-stage trial of oral ketamine tablets has shown promising results in treatment-resistant depression (TRD), setting ... Medicine and showed that a 180 mg dose of extended-release ketamine ...

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most ...